Free Trial

Haemonetics (HAE) SEC Filings & 10K Form

Haemonetics logo
$71.15
-0.87 (-1.21%)
(As of 10/31/2024 ET)

Recent Haemonetics SEC Filings

DateFilerForm TypeView
09/18/2024
3:18 PM
Haemonetics (Issuer)
Miller Laurie A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:20 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
5:04 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
5:05 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2024
3:23 PM
Haemonetics (Filer)
Form 8-K/A
07/29/2024
4:03 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:29 PM
COYLE MICHAEL J (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
Bryant Diane M (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:32 PM
ABERNATHY ROBERT E (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:34 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:21 PM
Haemonetics (Issuer)
Zane Ellen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
8:47 AM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
3:10 PM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
3:27 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
3:25 PM
Haemonetics (Subject)
Lingamneni Anila (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
3:42 PM
Haemonetics (Subject)
Lingamneni Anila (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
5:30 AM
Haemonetics (Filer)
Form DEFA14A
06/07/2024
5:31 AM
Haemonetics (Filer)
Form ARS
06/07/2024
5:26 AM
Haemonetics (Filer)
Form DEF 14A
05/29/2024
4:42 PM
Haemonetics (Issuer)
Llorens Josep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:44 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:27 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:31 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:35 PM
Haemonetics (Issuer)
Miller Laurie A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:38 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:06 PM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
10:06 AM
Basil Michelle L (Reporting)
Haemonetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
9:24 AM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
5:03 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
4:49 PM
Galvin Roy (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:52 PM
Haemonetics (Issuer)
Llorens Josep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:55 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:58 PM
Haemonetics (Issuer)
Miller Laurie A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
5:01 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
5:05 PM
Haemonetics (Issuer)
Maunsell Farris Maryanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:41 PM
DArecca James (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:46 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:38 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
10:13 AM
Basil Michelle L (Reporting)
Haemonetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2024
10:24 AM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2024
9:45 AM
Haemonetics (Subject)
Llorens Josep (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

05/20/2024
5:16 AM
Haemonetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/17/2024
4:11 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
3:52 PM
DArecca James (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
3:55 PM
Haemonetics (Issuer)
Llorens Josep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
11:15 AM
Basil Michelle L (Reporting)
Haemonetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
9:07 AM
Haemonetics (Subject)
Llorens Josep (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
11:57 AM
Haemonetics (Subject)
Llorens Josep (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
11:12 AM
Basil Michelle L (Reporting)
Haemonetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
11:15 AM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
5:04 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
3:21 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
1:08 PM
Haemonetics (Subject)
Lingamneni Anila (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
3:18 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
7:01 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
3:44 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:10 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
2:28 PM
Haemonetics (Subject)
Neuberger Berman Group LLC (Filed by)
Form SC 13G/A
02/09/2024
4:49 PM
Capital Research Global Investors (Filed by)
Haemonetics (Subject)
Form SC 13G/A
02/08/2024
9:21 AM
Haemonetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/08/2024
5:05 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2024
5:06 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/12/2023
5:09 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
3:36 PM
Galvin Roy (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
5:19 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
5:16 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:HAE) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners